aaic.alz.org

100%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site is known for its high journalistic standards. It strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. It has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

No current examples available.

Conflicts of Interest

No current examples available.

Contradictions

No current examples available.

Deceptions

No current examples available.

Recent Articles

  • New Weight Loss Drug Liraglutide Shows Promise in Slowing Cognitive Decline and Reducing Brain Shrinkage in Alzheimer's Patients: Potential Neuroprotective Effects

    New Weight Loss Drug Liraglutide Shows Promise in Slowing Cognitive Decline and Reducing Brain Shrinkage in Alzheimer's Patients: Potential Neuroprotective Effects

    Broke On: Tuesday, 30 July 2024 Liraglutide, a weight loss drug similar to Ozempic, shows potential in slowing cognitive decline and reducing brain shrinkage in patients with mild Alzheimer's disease according to recent research. The drug may have neuroprotective effects beyond managing diabetes and weight loss. Phase 3 clinical trials are expected to begin soon with potential FDA approval happening as early as next year.